Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Security class unavailable · CUSIP: 803607100
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,557,499
- Percent of class
- 6.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001140361-20-003315
- Form type
- SC 13G
- Filer
- SANDS CAPITAL MANAGEMENT, LLC
- CIK
- CIK 1020066
- Filed
- Feb 14, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership